This content is machine translated Type 2 diabetes Cardiovascular optimized therapy up-to-date The current ESC guideline recommends blood glucose-lowering substances with a proven cardiovascular benefit for certain risk groups among type 2 diabetics. In type 2 diabetes (T2D) and atherosclerotic cardiovascular disease…
View Post 4 min This content is machine translated Type 2 diabetes ESC recommendations for reducing cardiovascular risk Patients with type 2 diabetes have a greatly increased risk of developing cardiovascular disease compared to healthy people in the same age group. The current guidelines published in the European…
